Corporate News     08-Jan-21
J B Chemicals & Pharmaceuticals receives USFDA approval for Loratadine Tablets
J B Chemicals & Pharmaceuticals announced that US FDA has approved Company's Abbreviated New Drug Application (ANDA) for Loratadine Tablets USP 10 mg (for treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy) for over-the-counter (OTC) use. This product is generic version of Clartin® tablet in the same strength of Bayer Healthcare LLC.

The Company expects to commercialize this product in Q1 of FY 2021-22 and is expected to improve Company's US sales.

Previous News
  J B Chemicals & Pharmaceuticals fixes record date for final dividend
 ( Market Beat - Reports 11-Aug-21   18:57 )
  J B Chemicals & Pharmaceuticals fixes record date for final dividend
 ( Market Beat - Reports 29-Jul-22   18:52 )
  J B Chemicals & Pharmaceuticals allots 11,582 equity shares under ESOS
 ( Corporate News - 04-Jun-24   19:00 )
  J B Chemicals & Pharmaceuticals consolidated net profit rises 132.51% in the December 2020 quarter
 ( Results - Announcements 11-Feb-21   08:35 )
  J B Chemicals & Pharmaceuticals' facility at Panoli gets inspected by USFDA
 ( Corporate News - 27-Aug-18   13:12 )
  J B Chemicals & Pharmaceuticals standalone net profit declines 0.54% in the September 2018 quarter
 ( Results - Announcements 02-Nov-18   16:36 )
  J B Chemicals & Pharmaceuticals allots 43,450 equity shares under ESOS
 ( Corporate News - 05-Mar-24   18:45 )
  J B Chemicals & Pharmaceuticals to hold AGM
 ( Corporate News - 05-Jul-24   09:53 )
  J B Chemicals & Pharmaceuticals fixes record date for final dividend
 ( Market Beat - Reports 17-Aug-20   09:41 )
  J B Chemicals & Pharmaceuticals standalone net profit declines 59.15% in the June 2017 quarter
 ( Results - Announcements 11-Aug-17   16:38 )
  J B Pharma hits record high after Q3 PAT climbs 26% YoY
 ( Hot Pursuit - 07-Feb-24   15:53 )
Other Stories
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
Back Top